Pharmaceutical and biotechnology major Wockhardt announced the appointment of Mr V Suresh as president, finance.
A chartered accountant and a company secretary, he brings with him more than three decades of qualitative and multi-‐business experience at the highest level in the field of finance, accounting, strategy, projects, secretarial, business development, investment banking and consultancy and has handled comprehensive financial restructuring as well as internal financial management issues. With this appointment, Wockhardt has further strengthened its top management team adding depth to its finance department.
Mr V Suresh will take over charge from Mr Giri Giridhar, who will be leaving the organization on completion of all regulatory and mandatory audit of accounts for the FY 2012-13 to ensure a smooth handover of operations. With a large pool of patents and Intellectual Property know-how, Wockhardt is home to 578 scientists, of whom 80 are doctorates. In all, Wockhardt has 193 patents granted worldwide. In biotechnology research, it has built a
competent "Concept to Market" capability in all facets of
development and manufacture of recombinant biopharmaceuticals.
Wockhardt boasts of a multi-ethnic workforce of more than
7,900 people from 21 different nationalities.